| 查看: 204 | 回复: 2 | ||
| 【奖励】 本帖被评价2次,作者gxhfly增加金币 2 个 | ||
| 当前主题已经存档。 | ||
| 当前只显示满足指定条件的回帖,点击这里查看本话题的所有回帖 | ||
[资源]
[John Wiley 2009 新书]Photosensitisers in Biomedicine
|
||
|
Photosensitisers in Biomedicine Photosensitisers in Biomedicine. Publisher: John Wiley | Pages: 296 | 2009-04 | ISBN 0470510609 | PDF | 3 MB Photosensitisers in Biomedicine" offers clear and comprehensive coverage of the many different photosensitiser types, including information on their many applications that now extend beyond anticancer therapy. These applications now include photoantimicrobial treatments not only in microbial disease, but also in the microbial resistance to conventional drugs, which is circumvented by photomicrobial action. The application of photoantimicrobials in biological fluids is also of considerable importance in the current era of HIV and is discussed in the book.This text offers the most up-to-date coverage of photodynamic therapy including information on how photosensitisers have evolved within the field of cancer therapy and more recently antimicrobial research. There are few books on the market that take the approach of this text, as many are either conference based or focus on the chemistry of photosensitisers. "Photosensitisers in Biomedicine" is clearly defined into three distinct parts beginning with a clear introduction to the various types of photosensitisers. The book then moves on to discuss the chemistry of photosensitisers and closes with their numerous applications, for example, photodynamic therapy, photodiagnosis, photodynamic antimicrobial chemotherapy (PACT) and other non-oncological applications such as optical, arterial plaques and stents. http://depositfiles.com/en/files/gw94flgyf |
» 猜你喜欢
309分085801求调剂
已经有7人回复
生物学308分求调剂(一志愿华东师大)
已经有3人回复
求调剂:一志愿:南京大学 专业:0705 总分320 ,本科985,四六级已过
已经有3人回复
环境工程 085701,267求调剂
已经有14人回复
308求调剂
已经有12人回复
求调剂:085600材料与化工,考材科基,总分319
已经有21人回复
311求调剂
已经有8人回复
294分080500材料科学与工程求调剂
已经有13人回复
288求调剂 一志愿哈工大 材料与化工
已经有19人回复
288资源与环境专硕求调剂,不限专业,有学上就行
已经有23人回复
3楼2009-05-07 21:48:48














回复此楼